Fuller & Thaler Asset Management Inc. Acquires 4,679 Shares of Henry Schein, Inc. $HSIC

Fuller & Thaler Asset Management Inc. boosted its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 9.7% in the 1st quarter, Holdings Channel.com reports. The institutional investor owned 52,868 shares of the company’s stock after buying an additional 4,679 shares during the period. Fuller & Thaler Asset Management Inc.’s holdings in Henry Schein were worth $3,621,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. Investment Management Corp VA ADV bought a new stake in Henry Schein during the fourth quarter valued at $32,000. Rakuten Securities Inc. purchased a new stake in Henry Schein during the first quarter valued at about $34,000. Whittier Trust Co. raised its position in Henry Schein by 714.3% during the first quarter. Whittier Trust Co. now owns 798 shares of the company’s stock valued at $55,000 after purchasing an additional 700 shares in the last quarter. UMB Bank n.a. raised its position in Henry Schein by 23.2% during the first quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock valued at $73,000 after purchasing an additional 201 shares in the last quarter. Finally, Allworth Financial LP raised its position in Henry Schein by 24.5% during the first quarter. Allworth Financial LP now owns 1,178 shares of the company’s stock valued at $78,000 after purchasing an additional 232 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Up 0.5%

HSIC opened at $68.64 on Thursday. The company has a market cap of $8.32 billion, a P/E ratio of 22.14, a P/E/G ratio of 2.25 and a beta of 0.81. The business’s 50-day moving average price is $70.62 and its 200-day moving average price is $70.60. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 EPS for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The firm’s quarterly revenue was up 3.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities analysts expect that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Ratings Changes

HSIC has been the topic of a number of research reports. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 30th. Evercore ISI lowered their price target on Henry Schein from $78.00 to $70.00 and set an “in-line” rating on the stock in a research report on Wednesday, August 6th. UBS Group lowered their price target on Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 6th. Robert W. Baird restated a “neutral” rating and set a $72.00 price target (down previously from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Finally, Stifel Nicolaus restated a “hold” rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Four investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $75.58.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.